Case number 1:22-cv-01442
Pierre Fabre Medicament SAS, et al. v. Annora Pharma Private Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 22, 2023 | 45 | NOTICE OF SERVICE of Plaintiffs Disclosure Pursuant to Paragraph 7 of the Scheduling Order Regarding Claim Terms for Construction filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Simmons, John) (Entered: 06/22/2023) (2) |
| Jun 20, 2023 | 44 | SO ORDERED Granting 43 Stipulation of Infringement and Injunction. Signed by Judge Richard G. Andrews on 6/20/2023. (nms) (Entered: 06/20/2023) (3) |
| Jun 5, 2023 | 43 | STIPULATION of Infringement and Injunction by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Simmons, John) (Entered: 06/05/2023) (3) |
| May 12, 2023 | 42 | NOTICE OF SERVICE of Defendant Annora Pharma Private Limited's Initial Invalidity Contentions filed by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 05/12/2023) (2) |
| May 8, 2023 | 41 | NOTICE OF SERVICE of Defendant Annora Pharma Private Limited's Response to Plaintiffs' Second Set of Interrogatories (No. 6) filed by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 05/08/2023) (2) |
| Apr 19, 2023 | 40 | NOTICE OF SERVICE of (1) Annora's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-19) and; (2) Annora's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-5) filed by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 04/19/2023) (2) |
| Apr 17, 2023 | 39 | SO ORDERED Granting 38 Stipulation and Order to Substitute Pierre Fabre Medicament for Pierre Fabre Dermatologie and to Change Caption. Signed by Judge Richard G. Andrews on 4/17/2023. (nms) (Entered: 04/17/2023) (3) |
| Apr 14, 2023 | 38 | STIPULATION to Substitute Pierre Fabre Medicament for Pierre Fabre Dermatologie and to Change Caption, by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Simmons, John) Modified on 4/14/2023 (nms). (Entered: 04/14/2023) (3) |
| Apr 6, 2023 | 37 | NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendant (No. 6) filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 04/06/2023) (2) |
| Mar 31, 2023 | 36 | NOTICE OF SERVICE of Plaintiffs' Third Production of Documents marked PF0004174 - PF0010825 filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 03/31/2023) (2) |
| Mar 29, 2023 | 35 | NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendant's First Set of Interrogatories to Plaintiffs (Nos. 1-9), and (2) Plaintiffs' Responses and Objections to Defendant's First Set of Requests for Production (Nos. 1-13) filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 03/29/2023) (2) |
| Mar 20, 2023 | 34 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendant, and (2) Plaintiffs' First Set of Requests for Production to Defendant filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 03/20/2023) (2) |
| Mar 16, 2023 | 33 | NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Simmons, John) (Entered: 03/16/2023) (2) |
| Feb 27, 2023 | 32 | NOTICE OF SERVICE of (1) Defendant Annora Pharma Private Limited's First Set of Interrogatories to Plaintiffs (Nos. 1-9); and (2) Defendant Annora Pharma Private Limited's First Set of Requests for Production to Plaintiffs (Nos. 1-113) filed by Annora Pharma Private Limited.(Hitch, Cortlan) (Entered: 02/27/2023) (2) |
| Feb 15, 2023 | 31 | NOTICE OF SERVICE of Defendant Annora Pharma Private Limited's Paragraph 3 Disclosures filed by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 02/15/2023) (2) |
| Feb 15, 2023 | 30 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Delaware Default Standard for Discovery, Paragraph 3 filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 02/15/2023) (2) |
| Feb 13, 2023 | 29 | NOTICE OF SERVICE of Plaintiffs' Second Production of Documents marked PF00001378 to PF00004173 filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 02/13/2023) (2) |
| Feb 9, 2023 | 28 | SO ORDERED Granting 27 Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 2/9/2023. (nms) (Entered: 02/09/2023) (23) |
| Feb 9, 2023 | 27 | PROPOSED Stipulated Protective Order, by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Simmons, John) Modified on 2/9/2023 (nms). (Entered: 02/09/2023) (23) |
| Feb 8, 2023 | 24 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1)(A) filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 02/08/2023) (2) |
| Feb 8, 2023 | 25 | NOTICE OF SERVICE of Defendant Annora Pharma Private Limited's Rule 26(a)(1) Initial Disclosures filed by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 02/08/2023) (2) |
| Feb 8, 2023 | 26 | Joint Stipulation to Modify Scheduling Order extending the deadline for initial disclosures pursuant to Paragraph 3 of the Court's Default Standard for Discovery, Including Discovery of Electronically Stored Information to February 15, 2023, by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Simmons, John) Modified on 2/9/2023 (nms). (Entered: 02/08/2023) (2) |
| Feb 3, 2023 | 23 | Joint Stipulation to Modify Scheduling Order - filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Simmons, John) Modified on 2/3/2023 (nms). (Entered: 02/03/2023) (2) |
| Jan 31, 2023 | 21 | NOTICE OF SERVICE of Production of File Histories PF00000001-1377 filed by Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux.(Jones, Keith) (Entered: 01/31/2023) (2) |
| Jan 31, 2023 | 22 | NOTICE OF SERVICE of Annora's ANDA Document Production filed by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 01/31/2023) (2) |
| Jan 20, 2023 | 19 | SCHEDULING ORDER: This matter will be referred to a magistrate judge to handle all discovery disputes. Joinder of Parties due by 10/31/2023. Amended Pleadings due by 10/31/2023. Fact Discovery completed by 1/15/2024. Joint Claim Construction Brief due by 11/14/2023. A Markman Hearing is set for 12/6/2023, at9:00 AM in Courtroom 6A. A Pretrial Conference is set for 9/20/2024, at 9:00 AM in Courtroom 6A. A3 day Bench Trial is set to start on 9/30/2024, at 8:30 AM (see Order for further details). Signed by Judge Richard G. Andrews on 1/20/2023. (nms) (Entered: 01/20/2023) (11) |
| Jan 20, 2023 | 20 | ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Courts website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. Ordered by Judge Jennifer L. Hall on 1/20/2023. (ceg) (Entered: 01/20/2023) (0) |
| Jan 20, 2023 | 18 | PROPOSED Scheduling Order, by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Simmons, John) Modified on 1/20/2023 (nms). (Entered: 01/20/2023) (11) |
| Jan 3, 2023 | 17 | Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 1/23/2023, at 2:00 PM (see Order for further details). Signed by Judge Richard G. Andrews on 1/3/2023. (nms) (Entered: 01/03/2023) (1) |
| Jan 3, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney Richa B. Patel and Attorney Dennies Varughese - filed by Annora Pharma Private Limited. (Dorsney, Kenneth) (Entered: 01/03/2023) (4) |
| Dec 27, 2022 | 15 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd. for Annora Pharma Private Limited filed by Annora Pharma Private Limited. (Dorsney, Kenneth) (Entered: 12/27/2022) (2) |
| Dec 27, 2022 | 14 | ANSWER to 1 Complaint, by Annora Pharma Private Limited.(Dorsney, Kenneth) (Entered: 12/27/2022) (22) |
| Nov 22, 2022 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Alexander Alfano and Attorney Christopher M. Gallo - filed by Annora Pharma Private Limited. (Dorsney, Kenneth) (Entered: 11/22/2022) (4) |
| Nov 17, 2022 | 12 | STIPULATION for Extension of Time to answer, move or otherwise respond to the Complaint to December 27, 2022 - filed by Annora Pharma Private Limited. (Dorsney, Kenneth) Modified on 11/17/2022 (nms). (Entered: 11/17/2022) (2) |
| Nov 2, 2022 | 1 | Complaint* (1) |
| Nov 2, 2022 | 11 | SUMMONS Returned Executed by Universite de Bordeaux, Pierre Fabre Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Pharmaceuticals, Inc..Annora Pharma Private Limited served on 11/2/2022, answer due 11/23/2022. (Simmons, John) (Entered: 11/02/2022) (2) |
| Nov 2, 2022 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston - filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Attachments: # 1 Text of Proposed Order)(Simmons, John) (Entered: 11/02/2022) (Main Document) (3) |
| Nov 2, 2022 | 9 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Universite de Bordeaux. (Simmons, John) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 8 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pierre Fabre USA Inc. for Pierre Fabre Pharmaceuticals, Inc. filed by Pierre Fabre Pharmaceuticals, Inc.. (Simmons, John) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pierre Fabre Medicament SAS for Pierre Fabre Dermatologie filed by Pierre Fabre Dermatologie. (Simmons, John) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 5 | Summons Issued as to Annora Pharma Private Limited on 11/2/2022. (vfm) (Entered: 11/02/2022) (2) |
| Nov 2, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,338,489 B2 ;8,987,262 B2. (vfm) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/19/2022. Date of Expiration of Patent: 10/16/2028.Thirty Month Stay Deadline: 3/19/2025. (vfm) (Entered: 11/02/2022) (2) |
| Nov 2, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 11/02/2022) (3) |
| Nov 2, 2022 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston - filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Dermatologie, Pierre Fabre Pharmaceuticals, Inc., Universite de Bordeaux. (Attachments: # 1 Text of Proposed Order)(Simmons, John) (Entered: 11/02/2022) (Text of Proposed Order) (1) |
